ArticleCureus2024
Enhancing Healthcare Providers' Response to Gender-Based Violence: Development and Validation of an Assessment Tool Using the Modified e-Delphi Approach.
Article in Cureus, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background Effective gender-based violence (GBV) interventions depend on precise tools to assess healthcare providers' knowledge, attitudes, and practices (KAP). This study aimed to develop and validate a culturally appropriate GBV questionnaire on the KAP of healthcare workers in India using a modified e-Delphi method. Methodology The study used a modified e-Delphi approach, conducted online, to validate a GBV questionnaire. The process included the following three rounds: content validation, quantitative validation, and finalization. It began with a literature review and questionnaire drafting in May 2022, followed by validation from September 2022 to December 2023. The expert panel included healthcare professionals, public health experts, and researchers. The questionnaire included the following four sections: demographic information, knowledge of GBV, attitudes toward GBV, and GBV-related practices. Results In Round 1, significant revisions were made to enhance relevance and clarity, including the addition of a "Don't Know" option and revisions to questions on gender roles and societal expectations. The quantitative validation of Round 2 revealed high scores for Importance (4.980), Usefulness (4.965), Relevance (4.965), Clarity (4.955), Simplicity (4.980), and Ambiguity (4.815), with all items retained and no significant modifications. In Round 3, consensus was achieved, finalizing the questionnaire with expert validation certificates, demonstrating strong reliability and contextual appropriateness. Conclusions The validated KAP questionnaire is a reliable tool for assessing healthcare providers' capacity to manage GBV. It can be used to inform and enhance interventions aimed at improving GBV management in healthcare settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.